Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 18-Dec-23 6:46 PM View:  | Baker Bros Advisors LLC Director | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 44,708,500 | $229.00 | $10,238,199,808.00 | (100%) 44.71M to 0 | |
| 15-Dec-23 6:46 PM View: | Simonian Nancy A Director | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 62,753 | $229.00 | $14,370,400.00 | (100%) 62.75K to 0 | |
| 15-Dec-23 6:55 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 14,874 | $229.00 | $3,406,150.00 | (11%) 134.34K to 119.47K | |
| 15-Dec-23 6:16 PM View: | Gryska David W Director | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 49,003 | $229.00 | $11,221,700.00 | (100%) 49.0K to 0 | |
| 15-Dec-23 6:10 PM View: | Dansey Roger D President, R&D & CMO | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 38,338 | $229.00 | $8,779,400.00 | (100%) 38.34K to 0 | |
| 15-Dec-23 6:39 PM View: | Love Ted W Director | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 4,255 | $229.00 | $974,395.00 | (100%) 4.25K to 0 | |
| 15-Dec-23 6:29 PM View: | Epstein David R CEO Director | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 16,407 | $229.00 | $3,757,200.00 | (100%) 16.41K to 0 | |
| 15-Dec-23 6:31 PM View: | Welch Daniel G Director | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 4,750 | $229.00 | $1,087,750.00 | (31%) 15.47K to 10.72K | |
| 15-Dec-23 6:42 PM View: | Simpson Todd E Chief Financial Officer | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 93,292 | $229.00 | $21,363,900.00 | (100%) 93.29K to 0 | |
| 15-Dec-23 6:55 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 119,471 | $229.00 | $27,358,900.00 | (100%) 119.47K to 0 | |
| 15-Dec-23 6:10 PM View: | Orwin John A Director | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 29,003 | $229.00 | $6,641,690.00 | (100%) 29.0K to 0 | |
| 15-Dec-23 6:05 PM View: | Romp Charles R EVP, Commercial U.S. | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 33,796 | $229.00 | $7,739,280.00 | (100%) 33.8K to 0 | |
| 18-Dec-23 6:46 PM View: | Baker Bros Advisors LLC Director | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 46,557 | $229.00 | $10,661,600.00 | (< 1%) 44.76M to 44.71M | |
| 15-Dec-23 6:24 PM View: | Seth Alpna Director | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 12,953 | $229.00 | $2,966,240.00 | (100%) 12.95K to 0 | |
| 15-Dec-23 6:31 PM View: | Welch Daniel G Director | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 10,725 | $229.00 | $2,456,020.00 | (100%) 10.72K to 0 | |
| 15-Dec-23 6:32 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 48,748 | $229.00 | $11,163,300.00 | (100%) 48.75K to 0 | |
| 15-Dec-23 6:38 PM View: | Swain Sandra M Director | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 778 | $229.00 | $178,162.00 | (100%) 0.78K to 0 | |
| 13-Nov-23 8:02 PM View: | Epstein David R CEO Director | Seattle Genetics Inc. (SGEN) | 10-Nov-23 | Private Sale (Planned) | 10,620 | $213.01 | $2,262,170.00 | (7%) 147.22K to 136.6K | |
| 13-Nov-23 7:32 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 09-Nov-23 | Private Sale (Planned) | 8,785 | $213.32 | $1,874,050.00 | (5%) 170.83K to 162.04K | |
| 22-Sep-23 7:45 PM View: | Simpson Todd E Chief Financial Officer | Seattle Genetics Inc. (SGEN) | 21-Sep-23 | Private Sale (Planned) | 80 | $206.50 | $16,520.00 | (< 1%) 128.8K to 128.72K | |
| 22-Sep-23 7:46 PM View: | Romp Charles R EVP, Commercial U.S. | Seattle Genetics Inc. (SGEN) | 21-Sep-23 | Private Sale (Planned) | 45 | $206.50 | $9,292.50 | (< 1%) 69.16K to 69.11K | |
| 22-Sep-23 7:47 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 21-Sep-23 | Private Sale (Planned) | 64 | $206.50 | $13,216.00 | (< 1%) 84.46K to 84.4K | |
| 22-Sep-23 7:48 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 21-Sep-23 | Private Sale (Planned) | 80 | $206.50 | $16,520.00 | (< 1%) 170.91K to 170.83K | |
| 22-Sep-23 7:51 PM View: | Dansey Roger D President, R&D & CMO | Seattle Genetics Inc. (SGEN) | 21-Sep-23 | Sale (Planned) | 71 | $206.50 | $14,661.50 | (< 1%) 116.75K to 116.68K | |
| 08-Sep-23 5:09 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 07-Sep-23 | Option Exercise | 8,785 | $44.09 | $387,331.00 | 5% 170.91K to 179.69K | |
| 08-Sep-23 5:09 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 07-Sep-23 | Planned Option Sale | 8,785 | $205.76 | $1,807,600.00 | (5%) 179.69K to 170.91K | |
| 01-Sep-23 4:50 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 31-Aug-23 | Private Sale (Planned) | 1,893 | $206.97 | $391,786.00 | (2%) 86.36K to 84.46K | |
| 01-Sep-23 4:51 PM View: | Dansey Roger D President, R&D & CMO | Seattle Genetics Inc. (SGEN) | 31-Aug-23 | Private Sale (Planned) | 4,029 | $206.97 | $833,866.00 | (3%) 115.8K to 111.77K | |
| 01-Sep-23 4:51 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 31-Aug-23 | Private Sale (Planned) | 1,795 | $206.97 | $371,504.00 | (1%) 172.71K to 170.91K | |
| 01-Sep-23 4:49 PM View: | Simpson Todd E Chief Financial Officer | Seattle Genetics Inc. (SGEN) | 31-Aug-23 | Private Sale (Planned) | 2,122 | $206.97 | $439,182.00 | (2%) 130.93K to 128.8K | |
| 01-Sep-23 4:50 PM View: | Romp Charles R EVP, Commercial U.S. | Seattle Genetics Inc. (SGEN) | 31-Aug-23 | Private Sale (Planned) | 555 | $206.97 | $114,866.00 | (< 1%) 69.71K to 69.16K | |
| 30-Aug-23 7:08 PM View: | Dansey Roger D President, R&D & CMO | Seattle Genetics Inc. (SGEN) | 29-Aug-23 | Sale (Planned) | 1,016 | $206.00 | $209,296.00 | (< 1%) 116.81K to 115.8K | |
| 30-Aug-23 7:07 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 29-Aug-23 | Sale (Planned) | 371 | $206.00 | $76,426.00 | (< 1%) 173.08K to 172.71K | |
| 30-Aug-23 7:06 PM View: | Simpson Todd E Chief Financial Officer | Seattle Genetics Inc. (SGEN) | 29-Aug-23 | Sale (Planned) | 485 | $206.00 | $99,910.00 | (< 1%) 131.41K to 130.93K | |
| 30-Aug-23 7:06 PM View: | Romp Charles R EVP, Commercial U.S. | Seattle Genetics Inc. (SGEN) | 29-Aug-23 | Sale (Planned) | 438 | $206.00 | $90,228.00 | (< 1%) 70.15K to 69.71K | |
| 30-Aug-23 7:04 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 29-Aug-23 | Sale (Planned) | 405 | $206.00 | $83,430.00 | (< 1%) 86.76K to 86.36K | |
| 30-Aug-23 7:06 PM View: | Simpson Todd E Chief Financial Officer | Seattle Genetics Inc. (SGEN) | 28-Aug-23 | Grant | 1,225 | -- | -- | < 1% 130.19K to 131.41K | |
| 29-Aug-23 6:22 PM View: | Welch Daniel G Director | Seattle Genetics Inc. (SGEN) | 28-Aug-23 | Sale (Planned) | 1,610 | $209.08 | $336,619.00 | (8%) 19.13K to 17.52K | |
| 29-Aug-23 6:22 PM View: | Welch Daniel G Director | Seattle Genetics Inc. (SGEN) | 28-Aug-23 | Option Exercise | 1,812 | $135.63 | $245,762.00 | 9% 20.63K to 22.44K | 7% |
| 30-Aug-23 7:06 PM View: | Romp Charles R EVP, Commercial U.S. | Seattle Genetics Inc. (SGEN) | 28-Aug-23 | Grant | 1,107 | -- | -- | 2% 69.04K to 70.15K | |
| 29-Aug-23 6:22 PM View: | Welch Daniel G Director | Seattle Genetics Inc. (SGEN) | 28-Aug-23 | Planned Private Option Sale | 1,812 | $209.08 | $378,849.00 | (8%) 22.44K to 20.63K | |
| 30-Aug-23 7:08 PM View: | Dansey Roger D President, R&D & CMO | Seattle Genetics Inc. (SGEN) | 28-Aug-23 | Grant | 1,872 | -- | -- | 2% 114.94K to 116.81K | |
| 30-Aug-23 7:07 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 28-Aug-23 | Grant | 937 | -- | -- | < 1% 172.14K to 173.08K | |
| 29-Aug-23 6:22 PM View: | Welch Daniel G Director | Seattle Genetics Inc. (SGEN) | 28-Aug-23 | Sale (Planned) | 1,503 | $209.08 | $314,244.00 | (7%) 20.63K to 19.13K | |
| 30-Aug-23 7:04 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 28-Aug-23 | Grant | 1,022 | -- | -- | 1% 85.74K to 86.76K | |
| 17-Aug-23 9:13 PM View: | Himes Vaughn B Chief Technical Officer | Seattle Genetics Inc. (SGEN) | 16-Aug-23 | Disposition | 2,725 | $193.87 | $528,293.00 | (2%) 174.86K to 172.14K | |
| 17-Aug-23 9:13 PM View: | Liu Jean I Chief Legal Officer | Seattle Genetics Inc. (SGEN) | 16-Aug-23 | Disposition | 3,008 | $193.87 | $583,158.00 | (3%) 88.75K to 85.74K | |
| 17-Aug-23 8:47 PM View: | Simpson Todd E Chief Financial Officer | Seattle Genetics Inc. (SGEN) | 16-Aug-23 | Disposition | 3,507 | $193.87 | $679,898.00 | (3%) 133.69K to 130.19K | |
| 17-Aug-23 8:59 PM View: | Dansey Roger D President, R&D & CMO | Seattle Genetics Inc. (SGEN) | 16-Aug-23 | Disposition | 10,252 | $193.87 | $1,987,540.00 | (8%) 125.19K to 114.94K | |
| 17-Aug-23 9:00 PM View: | Romp Charles R EVP, Commercial | Seattle Genetics Inc. (SGEN) | 16-Aug-23 | Disposition | 3,134 | $193.87 | $607,585.00 | (4%) 72.18K to 69.04K |
